Torhild Garen - Concepedia

Author

Torhild Garen

Oslo University Hospital

Also Known As

Torhild Garen, Øyvind Midtvedt

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo Norwegian University of Science and Technology Hospital of Southern Norway University of California, Los Angeles

About

Torhild Garen is an author at Oslo University Hospital specializing in medicine, scleroderma, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	423
2	Public Health	1	1	115
3	Emergency Medicine	1	1	124
4	Epidemiology	1	1	115
5	Immunology	1	1	85

Torhild Garen

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort Anna‐Maria Hoffmann‐Vold, Håvard Fretheim, Anne‐Kristine Halse, American Journal of Respiratory and Critical Care Medicine	2019	244
Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease Helena Andersson, Marthe Sem, May Brit Lund, Lara D. Veeken	2015	208
Predictive Value of Serial High‐Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis Anna‐Maria Hoffmann‐Vold, Trond Mogens Aaløkken, May Brit Lund, Arthritis & Rheumatology	2015	151
Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort Cecilie Dobloug, Torhild Garen, Helle Bitter, Annals of the Rheumatic Diseases	2014	144
Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease Muriel Elhaï, Anna‐Maria Hoffmann‐Vold, Jérôme Avouac, Arthritis & Rheumatology	2019	134
Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis Anders H. Tennøe, Klaus Murbræch, Johanna C. Andreassen, Journal of the American College of Cardiology Heart FailureCardiovascular DiseaseSystemic SclerodermaSystemic SclerosisMedicine	2018	124
Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort Gerd Cecilie Dobloug, Torhild Garen, Cathrine Brunborg, Seminars in Arthritis and Rheumatism Rheumatoid DisorderRheumatologyCancer RiskAutoimmune DiseaseDisease Progression	2015	115
Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population‐Based Cohort Resident in Southern Norway B. Gudbrandsson, Øyvind Molberg, Torhild Garen, Arthritis Care & Research	2016	107
Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease Ragnar Gunnarsson, Fadi El-Hage, Trond Mogens Aaløkken, Lara D. Veeken	2015	92
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis Anna‐Maria Hoffmann‐Vold, Anders H. Tennøe, Torhild Garen, CHEST Journal InflammationPulmonary Function DeteriorationInflammatory Lung DiseaseAdvanced Lung DiseaseLung Inflammation	2016	85

Page 1